.
NCYT financial statements
* Numbers in millions
Year |
2017 | 2018 | 2019 | 2020 | TTM |
---|---|---|---|---|---|
Capitalization * |
1 474 | 1 318 | 915 | 60 346 | 12 120 |
EV * |
14 | 17 | 17 | 514 | 514 |
Stock price ¤ |
65 | 35 | 20 | 885 | 177.75 |
Number of shares * |
23 | 38 | 46 | 68 | 68 |
EPS |
-0,21 | -0,11 | -0,12 | 1,94 | 1,94 |
Revenue * |
13 | 12 | 11 | 277 | 277 |
Net income * |
-5 | -4 | -6 | 132 | 132 |
Operating profit * |
-2 | -1 | -1 | 175 | 175 |
Total liabilities * |
8 | 11 | 14 | 84 | 84 |
Net debt * |
0 | 4 | 8 | -89 | -89 |
Total assets * |
30 | 29 | 27 | 234 | 234 |
Equity * |
22 | 18 | 12 | 151 | 151 |
Cash and investments * |
4 | 1 | 2 | 92 | 92 |
Over the past 10 years, the maximum capitalization of Novacyt S.A. is 60 346, the minimum is 915. Maximum net income 132, Minimum net income -6. The maximum price of NCYT shares is 885, the minimum price is 20.
.
NCYT valuation
Year |
2017 | 2018 | 2019 | 2020 | TTM |
---|---|---|---|---|---|
P/E |
-3,05 | -3,09 | -1,63 | 4,56 | 0,92 |
P/B |
0,67 | 0,73 | 0,73 | 4,00 | 0,80 |
P/S |
1,11 | 1,07 | 0,82 | 2,18 | 0,44 |
E/P |
-33% | -32% | -61% | 22% | 109% |
P/FCF |
-2,62 | -6,83 | -6,49 | 5,93 | 1,19 |
.
NCYT profitability
Year |
2017 | 2018 | 2019 | 2020 | TTM |
---|---|---|---|---|---|
ROE |
-22% | -24% | -45% | 88% | |
ROA |
-43% | -41% | -61% | 62% | |
ROIC |
-8% | -3% | -5% | 109% |